The beloved clothing brand is set to undergo a strategic review after the controversial move in recent days – and it could see the firm change hands. Pictured: File photoRead More
You might also be interested in reading Tivic Health targets FDA approval for Entolimod within 18 months, highlights transformation into biopharma.